This NYTimes article talks about drug trials targeting p53 in cancer cells  but doesn't mention the kevetrin trials by Cellceutix.

You can register for a free account and click "recommend" on comments by biomanbaba and KarinCA. As of now, more than 67 "recommend" is the top Reader Picks comment.

Let's get in gear here, register, and get these comments as the top rated.

Here is the link for a free registration:

https://myaccount.nytimes.com/register

Here is the article:

http://www.nytimes.com/2012/12/23/health/new-...ancer.html